
    
      Multiple-dose, open-label, single-period study consisting of three consecutive phases: Phase
      A - run-in warfarin dose-finding phase Phase B - warfarin pharmacokinetics (PK) and
      international normalised ratio (INR) profiling Phase C - warfarin alone at their
      individualised doses
    
  